We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-13.9%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$8.16B
AUM Growth
+$248M
Cap. Flow
+$1.5B
Cap. Flow %
18.35%
Top 10 Hldgs %
14.12%
Holding
2,786
New
644
Increased
646
Reduced
549
Closed
902

Top Buys

Rank Stock Value
1
ETR icon
Entergy
ETR
+$79.1M
2
DTE icon
DTE Energy
DTE
+$73.2M
3
FDX icon
FedEx
FDX
+$48.6M
4
MPC icon
Marathon Petroleum
MPC
+$47.5M
5
CMS icon
CMS Energy
CMS
+$45.3M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$75.8M
2
XOM icon
ExxonMobil
XOM
+$62M
3
LIN icon
Linde
LIN
+$49.9M
4
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$38.6M
5
EXPE icon
Expedia Group
EXPE
+$29.7M

Sector Composition

Rank Sector Weight
1 Industrials 14.24%
2 Technology 13.54%
3 Utilities 9.55%
4 Financials 8.68%
5 Healthcare 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PVH icon
2351
PVH
PVH
$3.62B
-14,391
Closed -$1.1M
PWP icon
2352
Perella Weinberg Partners
PWP
$1.23B
-55,868
Closed -$528K
QSI icon
2353
Quantum-Si Incorporated
QSI
$183M
-213,552
Closed -$999K
RAMP icon
2354
LiveRamp
RAMP
$2.28B
-30,439
Closed -$1.14M
RBLX icon
2355
Roblox
RBLX
$27.4B
-6,431
Closed -$297K
RBOT
2356
DELISTED
Vicarious Surgical
RBOT
-4,069
Closed -$618K
RDVT icon
2357
Red Violet
RDVT
$1.14B
-34,284
Closed -$977K
RDW icon
2358
Redwire
RDW
$3B
-39,791
Closed -$337K
LNAI
2359
Lunai Bioworks
LNAI
$9.75M
-639
Closed -$422K
REZI icon
2360
Resideo Technologies
REZI
$3.08B
-13,003
Closed -$310K
RGA icon
2361
Reinsurance Group of America
RGA
$15.9B
-1,896
Closed -$208K
RGP icon
2362
Resources Connection
RGP
$149M
-14,961
Closed -$256K
RGTI icon
2363
Rigetti Computing
RGTI
$5.98B
-101,515
Closed -$640K
RH icon
2364
CALL
RH
RH
$2.9B
-40,000
Closed -$13M
RIGL icon
2365
Rigel Pharmaceuticals
RIGL
$857M
-41,877
Closed -$1.25M
RIOT icon
2366
Riot Platforms
RIOT
$7.44B
-37,314
Closed -$790K
RJF icon
2367
Raymond James Financial
RJF
$33.7B
-48,770
Closed -$5.36M
RKLB icon
2368
Rocket Lab Corp
RKLB
$46.4B
-49,091
Closed -$395K
RKT icon
2369
Rocket Companies
RKT
$39.4B
-47,286
Closed -$526K
RLI icon
2370
RLI Corp
RLI
$6B
-35,476
Closed -$1.96M
RDNW
2371
RideNow Group
RDNW
$233M
-32,663
Closed -$1.12M
RNAC icon
2372
Cartesian Therapeutics
RNAC
$304M
-432
Closed -$16K
ROK icon
2373
Rockwell Automation
ROK
$48.5B
-93,627
Closed -$26.2M
RPRX icon
2374
Royalty Pharma
RPRX
$27.3B
-93,492
Closed -$3.64M
RSKD icon
2375
Riskified
RSKD
$779M
-45,189
Closed -$273K

Similar funds

Michael Gelband's Q2 2022 Portfolio in Review

As of Q2 2022, Michael Gelband held 2,786 positions worth $8.16B, up 3.1% from $7.91B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Michael Gelband deployed $1.5B of net new capital in Q2 2022, opening 644 new positions and adding to 646 existing holdings. Its largest new stake was Marathon Petroleum: 508,082 shares worth $41.8M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Utilities.

On the sell side, the largest reduction was AT&T, an estimated $75.8M trimmed.

  • Michael Gelband's largest Q2 2022 buy was Marathon Petroleum: 508,082 shares worth $41.8M.
  • Michael Gelband added most to Entergy in Q2 2022, an estimated $79.1M increase.
  • Michael Gelband's biggest Q2 2022 reduction was AT&T, cutting an estimated $75.8M.
  • Michael Gelband fully exited Linde in Q2 2022, selling an estimated $49.9M.
  • Michael Gelband's ten largest holdings make up 14% of its $8.16B portfolio in Q2 2022.
  • Michael Gelband opened 644 new positions and closed 902 in Q2 2022.
  • Michael Gelband's portfolio value rose 3.1% quarter-over-quarter to $8.16B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.